FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.160
-0.060 (-4.92%)
Apr 28, 2025, 9:44 AM EDT - Market open
FibroBiologics Employees
FibroBiologics had 13 employees as of December 31, 2024. The number of employees increased by 3 or 30.00% compared to the previous year.
Employees
13
Change (1Y)
3
Growth (1Y)
30.00%
Revenue / Employee
n/a
Profits / Employee
-$858,538
Market Cap
44.38M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
FBLG News
- 17 days ago - FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean - GlobeNewsWire
- 20 days ago - FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics - GlobeNewsWire
- 26 days ago - FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair - GlobeNewsWire
- 27 days ago - FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - FibroBiologics Announces 2025 Annual Meeting of Stockholders - GlobeNewsWire
- 5 weeks ago - FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting - GlobeNewsWire
- 7 weeks ago - FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics - GlobeNewsWire
- 2 months ago - FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic - GlobeNewsWire